Dramatic regression of conjunctival and corneal acquired melanosis with topical mitomycin C [2]

British Journal of Ophthalmology

Volumn 86, Issue 2, 2002, Pages 244-245

  Shields, Carol L ^a   Demirci, Hakan ^a   Shields, Jerry A ^a   Spanich, Christopher ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C;

AGED; CASE REPORT; CLINICAL EXAMINATION; CONJUNCTIVA DISEASE; CORNEA DISEASE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; MELANOSIS; PIGMENTATION; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; EYE NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOSIS; MITOMYCIN; PRECANCEROUS CONDITIONS;

EID: 0036158958     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.2.244     Document Type: Letter

References (7)

1. Conjunctival malignant melanoma: Risks for recurrence, exenteration, metastasis, and death in 150 cases
2. Melanocytic tumors
3. Clinical characterization of primary acquired melanosis
4. Conjunctival melanosis and melanoma
5. Surgical management of conjunctival tumors: The 1994 Lynn B. McMahan Lecture
6. Topical mitomycin C chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia
7. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia. A multicenter experience